Article Type
Changed
Thu, 06/20/2019 - 13:10
Display Headline
CLINICAL UPDATE: The Treatment of Atopic Dermatitis

 

[[{"attributes":{},"fields":{}}]]A Clinical Update Supplement to Skin & Allergy News®.  This supplement was sponsored by Valeant Dermatology 

 

Topics

 

  • Introduction
  • Nonpharmacologic Management of AD
  • Pharmacologic Management of AD
  • Conclusions

 

Faculty/Faculty Disclosure

 

Joseph F. Fowler, Jr., MD, FAAD

 

Clinical Professor of Dermatology

 

University of Louisville, KY

 

Dr Fowler has received funding for clinical grants from Valeant Pharmaceuticals International, Inc., and is a consultant to Galderma Laboratories, L.P., GlaxoSmithKline plc., Stiefel Laboratories, Inc., and Valeant.

 

Copyright © 2012 Elsevier Inc.
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

 

[[{"attributes":{},"fields":{}}]]A Clinical Update Supplement to Skin & Allergy News®.  This supplement was sponsored by Valeant Dermatology 

 

Topics

 

  • Introduction
  • Nonpharmacologic Management of AD
  • Pharmacologic Management of AD
  • Conclusions

 

Faculty/Faculty Disclosure

 

Joseph F. Fowler, Jr., MD, FAAD

 

Clinical Professor of Dermatology

 

University of Louisville, KY

 

Dr Fowler has received funding for clinical grants from Valeant Pharmaceuticals International, Inc., and is a consultant to Galderma Laboratories, L.P., GlaxoSmithKline plc., Stiefel Laboratories, Inc., and Valeant.

 

Copyright © 2012 Elsevier Inc.

 

[[{"attributes":{},"fields":{}}]]A Clinical Update Supplement to Skin & Allergy News®.  This supplement was sponsored by Valeant Dermatology 

 

Topics

 

  • Introduction
  • Nonpharmacologic Management of AD
  • Pharmacologic Management of AD
  • Conclusions

 

Faculty/Faculty Disclosure

 

Joseph F. Fowler, Jr., MD, FAAD

 

Clinical Professor of Dermatology

 

University of Louisville, KY

 

Dr Fowler has received funding for clinical grants from Valeant Pharmaceuticals International, Inc., and is a consultant to Galderma Laboratories, L.P., GlaxoSmithKline plc., Stiefel Laboratories, Inc., and Valeant.

 

Copyright © 2012 Elsevier Inc.
Publications
Publications
Article Type
Display Headline
CLINICAL UPDATE: The Treatment of Atopic Dermatitis
Display Headline
CLINICAL UPDATE: The Treatment of Atopic Dermatitis
Sections
Disallow All Ads
Alternative CME
Disqus Comments
Off